| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 116 / 151 | 23rd | Q4 |
| Oncology | 329 / 428 | 23rd | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Blood Neoplasia
Blood Neoplasia is Scopus-indexed (Q4, CiteScore 1.1), DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2950-3280Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Blood Neoplasia indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q4, CiteScore 1.1.
What quartile is Blood Neoplasia in Scopus?
Blood Neoplasia is Q4 in Hematology (rank 116 of 151) and Q4 in Oncology (rank 329 of 428), by CiteScore 2025.
What is the impact factor of Blood Neoplasia?
Blood Neoplasia is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.1, quartile Q4, 23rd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.181, quartile Q1, with an H-index of 6.
How much does it cost to publish in Blood Neoplasia?
The publisher lists an article processing charge of about US$3,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Blood Neoplasia and what is its ISSN?
Blood Neoplasia is published by Elsevier B.V. Its ISSN is 2950-3280.
Is Blood Neoplasia in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Blood Neoplasia open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Blood Neoplasia? — open metrics via OpenAlex
Blood Neoplasia has an h-index of 11 and a 2-year mean of 1.99 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q4. On 2-year citations it ranks #49 of 148 Scopus journals in Hematology.
Blood Neoplasia published 126 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Blood Neoplasia? — latest 97 articles, 2026
In its latest 97 research articles (2026), authors are most often from United States (57.9%), United Kingdom (5.4%) and Canada (4.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Blood Neoplasia? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration57.9% of recent authorship from United States
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.